Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo

Journal of the American Society of Nephrology

Volumn 14, Issue 1, 2003, Pages 37-45

  Cavarape, Alessandro ^a,d   Endlich, Nicole ^b   Assaloni, Roberta ^a   Bartoli, Ettore ^b   Steinhausen, Michael ^c   Parekh, Niranjan ^b   Endlich, Karlhans ^b  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c UNIVERSITY OF EASTERN PIEDMONT   (Italy)

^d Department of Medicine ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; 6 N CYCLOPENTYLADENOSINE; ADENOSINE A1 RECEPTOR AGONIST; ADENYLATE CYCLASE; ENDOTHELIN B RECEPTOR AGONIST; F ACTIN; FASUDIL; GUANYLATE CYCLASE INHIBITOR; MYOSIN LIGHT CHAIN KINASE; PROTEIN KINASE C INHIBITOR; PROTEIN KINASE INHIBITOR; RHO KINASE; SUCCINYLENDOTHELIN 1 [8-21][9 GLUTAMIC ACID 11,15 ALANINE];

ANIMAL MODEL; ARTICLE; BLOOD VESSEL DIAMETER; BLOOD VESSEL TONE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DOSE RESPONSE; ENZYME ACTIVATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; GLOMERULUS; HYDRONEPHROSIS; KIDNEY BLOOD FLOW; MICROCIRCULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; VASOCONSTRICTION; VASODILATATION;

EID: 12244285281     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000039568.93355.85     Document Type: Article

References (54)

1. Horowitz A, Menice CB, Laporte R, Morgan KG: Mechanisms of smooth muscle contraction. Physiol Rev 76: 967-1003, 1996
2. Somlyo AP, Somlyo AV: Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and nonmuscle myosin II. J Physiol 522: 177-185, 2000
3. Pfitzer G: Regulation of myosin phosphorilation in smooth muscle. J Appl Physiol 91: 497-503, 2001
4. Amano M, Ito M, Kimura K, Fukata Y, Chihara K, Nakano T, Matsuura Y, Kaibuchi K: Phosphorylation and activation of myosin by Rho-associated kinase (Rho-kinase). J Biol Chem 271:20246-20249, 1996
5. MacDonald JA, Borman MA, Muranyi A, Somlyo AV, Hartshorne DJ, Haystead TA: Identification of the endogenous smooth muscle myosin phosphatase-associated kinase. Proc Natl Acad Sci USA 98: 2419-2424, 2001
6. Eto M, Ohmori T, Suzuki M, Furuya K, Morita F: A novel protein phosphatase-1 inhibitory protein potentiated by protein kinase C. Isolation from porcine aorta media and characterization. J Biochem 118: 1104-1107, 1995
7. Eto M, Kitazawa T, Yazawa M, Mukai H, Ono Y, Brautigan DL: Histamine-induced vasoconstriction involves phosphorylation of a specific inhibitor protein for myosin phosphatase by protein kinase C α and δ isoforms. J Biol Chem 276: 29072-29078, 2001
8. Batchelor TJ, Sabada JR, Ishola A, Pacaud P, Munsch CM, Beech D: Rho-kinase inhibitors prevent agonist-induced vasospasm in internal mammary artery. Br J Pharmacol 132: 302-308, 2001
9. 13 in agonist-induced vascular smooth muscle cell contraction. Circ Res 87: 221-227, 2000
10. Lucius CA, Anders A, Steusloff M, Troschka F, Hofmann K, Aktories K, Pfitzer G: Clostridium difficile toxin B inhibits carbachol-induced force and myosin light chain phosphorylation in guinea-pig smooth muscle: Role of Rho proteins. J Physiol 506:83-93, 1998
11. Uehata M, Ishizaki T, Satoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S: Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature 389: 990-994, 1997
12. Masumoto A, Hirooka Y, Shimokawa H, Hironaga K, Setoguchi S, Takeshita A: Possible involvement of Rho-kinase in the pathogenesis of hypertension in humans. Hypertension 38: 1307-1310, 2001
13. Sato S, Ikegaki I, Asano T, Shimokawa H: Antiischemic properties of fasudil in experimental models of vasospastic angina. Jpn J Pharmacol 87: 34-40, 2001
14. Navar LG, Inscho EW, Majid DAS, Imig JD, Harrison-Bernard LM, Mitchell KD: Paracrine regulation of renal microcirculation. Physiol Rev 76: 425-536, 1996
15. Seguchi H, Nishimura J, Toyofuku K, Kobayashi S, Kumazawa J, Kanaide H: The mechanism of relaxation induced by atrial natriuretic peptide in the porcine renal artery. Br J Pharmacol 118:343-351, 1996
16. Kaibuchi K, Kuroda S, Amano M: Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem 68: 459-486, 1999
17. Matrougui K, Tanko LB, Loufrani L, Gorny D, Levy BI, Tedgui A, Henrion D: Involvement of Rho-kinase and the actin filament network in angiotensin II-induced contraction and extracellular signal-regulated kinase activity in intact rat mesenteric resistance arteries. Arterioscler Thromb Vasc Biol 21: 1288-1293, 2001
18. Cavarape A, Endlich K, Feletto F, Parekh N, Bartoli E, Steinhausen M: Contribution of endothelin receptors in renal microvessels in acute cyclosporine-mediated vasoconstriction in rats. Kidney Int 53: 963-969, 1998
19. Wayland H, Johnson P: Erythrocyte velocity measurement in microvessels by a two slit-photometric method. J Appl Physiol 22: 333-337, 1967
20. Gaethgens P: Flow of blood through narrow capillaries: Rheological mechanisms determining capillary hematocrit and apparent viscosity. Biorheology 17: 183-189, 1980
21. Steinhausen M, Blum M, Fleming JT, Holz FG, Parekh N, Wiegman DL: Visualization of renal autoregulation in the split hydronephrotic kidney of rats. Kidney Int 35: 1151-1160, 1989
22. B receptor-mediated constriction in the renal microcirculation of rats. J Physiol 497: 211-218, 1996
23. Dietrich MS, Endlich K, Parekh N, Steinhausen M: Interaction between adenosine and angiotensin II in renal microcirculation. Microvasc Res 41: 275-288, 1991
24. Holz FG, Steinhausen M: Renovascular effects of adenosine receptor agonists. Renal Physiol 10: 272-282, 1987
25. Endlich K, Steinhausen M: Role of kinins and angiotensin II in the vasodilating action of angiotensin converting enzyme inhibition in rat renal vessels. J Hypertens 15: 633-641, 1997
26. Gabriels G, Endlich K, Rahn KH, Schlatter E, Steinhausen M: In vivo effects of diadenosine polyphosphates on rat renal microcirculation. Kidney Int 57: 2476-2484, 2000
27. Davies SP, Reddy H, Caivano M, Cohen P: Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J 351: 95-105, 2000
28. Lanese DM, Conger JD: Effects of endothelin receptor antagonist on cyclosporine-induced vasoconstriction in isolated rat renal arterioles. J Clin Invest 91: 2144-2149, 1993
29. Loutzenhiser R, Epstein M, Hayashi K, Horton C: Direct visualization of effects of endothelin on the renal microvasculature. Am J Physiol 258: F61-F68, 1990
30. Loutzenhiser R, Epstein M, Hayashi K, Takenaka T, Forster H: Characterization of the renal microvascular effects of angiotensin II antagonist, DuP 753: Studies in isolated perfused hydronephrotic kidneys. Am J Hypertens 4: 309S-314S, 1991
31. Welsch T, Endlich N, Kriz W, Endlich K: CD2AP and p130Cas localize to different F-actin structures in podocytes. Am J Physiol Renal Physiol 281: F769-F777, 2001
32. Asano T, Suzuki T, Tsuchiya M, Satoh S, Ikegaki I, Shibuya M, Suzuki Y, Hidaka H: Vasodilator actions of HA1077 in vitro and in vivo putatively mediated by the inhibition of protein kinase. Br J Pharmacol 98: 1091-1100, 1989
33. Sakurada S, Okamoto H, Takuwa N, Sugimoto N, Takuwa Y: Rho activation in excitatory agonist-stimulated vascular smooth muscle. Am J Physiol Cell Physiol 281: C571-C578, 2001
34. 13. Am J Physiol 276: C930-C937, 1999
35. Matsumura Y, Kita S, Okui T: Mechanisms of endothelin-1-induced potentiation of noradrenaline response in rat mesenteric artery. Clin Exp Pharmacol Physiol 28: 36999-37003, 2001
36. Mills TM, Chitaley K, Wingard CJ, Lewis RW, Webb RC: Effect of Rho-kinase inhibition on vasoconstriction in the penile circulation. J Appl Physiol 91: 1269-1273, 2001
37. Nakamura K, Nishimura J, Hirano K, Ibayashi S, Fujishima M, Kanaide H: Hydroxyfasudil, an active metabolite of fasudil hydrochloride, relaxes the rabbit basilar artery by disinhibition of myosin light chain phosphatase. J Cereb Blood Flow Metab 21: 876-885, 2001
38. 2+ sensitization of smooth muscle of porcine coronary artery. J Cardiovasc Pharmacol 35: 814-821, 2000
39. Yamamoto Y, Ikegaki I, Sasaki Y, Uchida T: The protein kinase inhibitor fasudil protects against ischemic myocardial injury induced by endothelin-1 in the rabbit. J Cardiovasc Pharmacol 35: 203-211, 2000
40. Nagahama T, Hayashi K, Ozawa Y, Takenaka T, Saruta T: Role of protein kinase C in angiotensin II-induced constriction of renal microvessels. Kidney Int 57: 215-223, 2000
41. Fetscher C, Chen H, Schafers RF, Wambach G, Heusch G, Michel MC: Modulation of noradrenaline-induced microvascular constriction by protein kinase inhibitors. Naunyn Schmiedebergs Arch Pharmacol 363: 57-65, 2001
42. Sun CW, Falck JR, Harder DR, Roman RJ: Role of tyrosine kinase and PKC in the vasoconstrictor response to 20-HETE in renal arterioles. Hypertension 33: 414-418, 1999
43. Sun D, Samuelson LC, Yang T, Huang Y, Paliege A, Saunders T, Briggs J, Schnermann J: Mediation of tubuloglomerular feedback by adenosine: Evidence from mice lacking adenosine 1 receptors. Proc Natl Acad Sci USA 98: 9983-9988, 2001
44. Gabbai FB, Blantz RC: Role of nitric oxide in renal hemodynamics. Semin Nephrol 19: 242-250, 1999
45. Hoffend J, Cavarape A, Endlich K, Steinhausen M: Influence of endothelium-derived relaxing factor on renal microvessels and pressure-dependent vasodilation. Am J Physiol 265: F285-F292, 1993
46. Trottier G, Triggle CR, O'Neill SK, Loutzenhiser R: Cyclic GMP-dependent and cyclic GMP-independent actions of nitric oxide in the renal afferent arteriole. Br J Pharmacol 125: 563-569, 1998
47. Lang P, Gesbert F, Delespine-Carmagnat M, Stancou R, Pouchelet M, Bertoglio J: Protein kinase A phosphorylation of RhoA mediates the morphological and functional effects of cyclic AMP in cytotoxic lymphocytes. EMBO J 15: 510-519, 1996
48. 2+ Sensitisation of contraction in vascular smooth muscle. J Biol Chem 275: 21722-21729, 2000
49. Sawada N, Itoh H, Yamashita J, Doi K, Inoue M, Masatsugu K, Fukunaga Y, Sakaguchi S, Sone M, Yamahara K, Yurugi T, Nakao K: cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem Biophys Res Commun 280: 798-805, 2001
50. Sauzeau V, Le Mellionnec E, Bertoglio J, Scalbert E, Pacaud P, Loirand G: Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ Res 88: 1102-1104, 2001
51. Jiang J, Sun CW, Alonso-Galicia M, Roman RJ: Lovastatin reduces renal vascular reactivity in spontaneously hypertensive rats. Am J Hypertens 11: 1222-1231, 1998
52. Andresen BT, Jackson EK, Romero GG: Angiotensin II signaling to phospholipase D in renal microvascular smooth muscle cells in SHR. Hypertension 37: 635-639, 2001
53. Fleming JT, Parekh N, Steinhausen M: Calcium antagonists preferentially dilate preglomerular vessels of hydronephrotic kidney. Am J Physiol 253: F1157-F1163, 1987
54. Hansen PB, Jensen BL, Andreasen D, Skott O: Differential expression of T- and L-type voltage-dependent calcium channels in renal resistance vessels. Circ Res 89: 630-638, 2001